Previous Article | Next Article ![]()
Journal of Virology, June 2000, p. 5347-5351, Vol. 74, No. 11
Laboratory of Molecular and Cellular
Biophysics, National Institute of Child Health and Human Development,
National Institutes of Health, Bethesda, Maryland
20892,1 and Gladstone Institute of
Virology and Immunology,2 and
Departments of Medicine4 and
Pathology,3 School of Medicine,
University of California at San Francisco, San Francisco,
California 94141-9100
Received 22 July 1999/Accepted 25 February 2000
The present study sought to determine how usage of coreceptors by
human immunodeficiency virus type 1 dictates cell tropism and depletion
of CD4+ T cells in human lymphoid tissues cultured ex vivo.
We found that coreceptor preferences control the marked, preferential
depletion of coreceptor-expressing CD4+ lymphocytes. In
addition, there was a strong, but not absolute, preference shown by
CXCR4-using strains for lymphocytes and by CCR5-using strains for macrophages.
The hallmark of human
immunodeficiency virus type 1 (HIV-1) disease is the progressive
depletion of CD4+ lymphocytes. Different strains of HIV
vary with respect to their target cell range and cytopathic potential.
The molecular basis for differential cell tropism and virulence
remained obscure until the discovery of select chemokine receptors that
act as essential cofactors for cellular entry by HIV-1 (1).
We previously reported that HIV-1 envelope glycoprotein (gp120)
determinants controlling a preference for CXCR4 resulted in marked
depletion of CD4+ T cells in human lymphoid histocultures,
while those specifying a preference for CCR5 resulted in only mild
depletion of such cells. These results suggested that either X4 viruses
are intrinsically more cytopathic than R5 viruses or viruses with
different coreceptor specificities target quantitatively distinct
CD4+ T-cell pools. Our earlier study established that R5
HIV-1 variants exclusively deplete CCR5-expressing CD4+
lymphocytes, while X4 HIV-1 variants preferentially deplete
CXCR4-expressing cells (5). However, the diverse HIV-1
isolates used in this work differed from each other by many parameters
other than coreceptor usage that could influence cytopathicity.
The present study sought to establish a specific causative relationship
among coreceptor usage, tropism, and CD4+ T-cell depletion
in mature lymphoid tissue. Human tonsil histocultures were inoculated
with pairs of recombinant strains of HIV-1 that differ exclusively in
small regions of gp120 that control coreceptor preference. Three pairs
of viruses based on an isogenic (NL4-3) viral backbone were studied:
(i) NL4-3 (X4) and 49-5 (R5), virus chimeras that differ only in the
gp120 V3 loop region that specifies strict reciprocal tropism for CXCR4
and CCR5, respectively (9, 12, 13); (ii) 134 (X4) and 126 (R5), site-directed mutants that differ in a single V3 amino acid
residue that likewise dictates preference for CXCR4 or CCR5,
respectively (3, 12); and 123 (X4) and USV3 (R5), chimeras
that contain V3 loop segments derived from primary X4 and R5 viral
isolates (references 3 and 12 and
unpublished data).
T-cell depletion and viral replication were measured 12 to 15 days
following inoculation as described previously (4).
Consistent with our earlier report (9), NL4-3 (X4) severely
depleted these cultures of CD4+ T cells, while the paired
virus 49-5 (R5) depleted these cells only mildly (Fig.
1A). Recombinant strain 134 (X4) also
severely depleted these cells, while its paired strain, 126 (R5), which differs by a single amino acid within the V3 loop region, mildly depleted these cells (Fig. 1A). Viruses 123 and USV3, which encode V3
loop segments derived from primary viral isolates, likewise depleted
CD4+ T cells according to coreceptor usage (Fig. 1A). These
results confirm and extend previous observations by demonstrating that sequences within the V3 loop that control coreceptor preference dictate
severe or mild CD4+ lymphocyte depletion. We have shown
previously (9) and verified here for each virus pair (see
Fig. 3) (data not shown) that the differential depletion effects occur
despite comparable viral replication kinetics.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 1 Coreceptor
Preferences Determine Target T-Cell Depletion and Cellular Tropism
in Human Lymphoid Tissue
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (31K):
[in a new window]
FIG. 1.
CD4+ T-cell depletion in human tonsil
histocultures infected ex vivo by matched HIV-1 strains. (A) Left:
CD4+ T-cell depletion as indicated by mean relative CD4/CD8
ratio on day 15 after infection by recombinant viruses NL4-3, 49-5, 134, and 126. For each data point, cells were pooled from 6 to 10 tissue blocks (mean plus standard error of the mean, n = 3) and analyzed by flow cytometry. Right: CD4 depletion on day 13 by viruses 123 and USV3, which were tested in a separate experiment.
Presented are data from typical experiments with tissues from two to
five donors. (B) CD4+ T-cell subset depletion data as
indicated by the relative CD4/CD8 ratio for the CCR5
or
CCR5+ T-cell subsets in the tissue samples presented in
panel A.
To test the hypothesis that target cell availability influences the
magnitude of cellular depletion by each viral strain, we used flow
cytometry to determine the relative prevalence of potential target
cells as defined by CXCR4 and CCR5 expression. CXCR4 was expressed on
the overwhelming majority of CD4+ T cells in resting
tissues (mean, 88.5% ± 1.6%, n = 25), whereas CCR5
expression was restricted to a much smaller subset of these cells
(mean, 10.4% ± 0.8%, n = 25) (reference
5 and data not shown). We determined whether these
expression profiles are linked to preferential depletion by inoculating
histocultures with viruses that vary only in coreceptor phenotype.
Since CXCR4 is widely expressed on both CCR5+ and
CCR5
cells, our hypothesis predicts that X4 viruses would
deplete cells in both subsets, whereas R5 viruses would deplete
preferentially within the CCR5+ subset. We therefore
focused our analysis on quantitation of the CCR5+ and
CCR5
subsets of CD4+ lymphocytes following
infection. Indeed, all three of the X4 viruses (NL4-3, 134, and 123)
massively and comparably depleted both CCR5
and
CCR5+ cells, while the R5 viruses (49-5, 126, and USV3)
caused depletion preferentially within the CCR5+ subset and
comparatively modest depletion within the CCR5
subset
(Fig. 1B). We speculate, but cannot prove, that the partial depletion
of CCR5
cells by R5 viruses is explained by subthreshold
levels of CCR5 expression on some cells, since previous work
established that certain CD4+ lymphocytes that do not
express CCR5 at levels detectable by flow cytometric methods were
infectable by R5 viruses (11). Nonetheless, in all of our
experiments, depletion within the CCR5+ subset by R5
viruses exceeded that in the CCR5
subset by twofold or
more. These results together demonstrate that envelope-determined
coreceptor preferences direct the selective depletion of cognate
coreceptor-expressing CD4+ lymphocytes in human lymphoid histocultures.
Despite a marked difference in the frequencies of potential cell
targets for X4 and R5 viruses and the selective depletion of targets by
each virus type, the replication kinetics of these viruses based on
virus production were quite similar. Although the absolute levels of
virus replication varied among individual tissue donors, there were no
consistent differences in the peak levels of viral replication or the
kinetics of virus accumulation in the culture medium upon inoculation
of any particular tissue specimen by pairs of X4 and R5 strains. To
elucidate further the relationship between virus-induced
CD4+ T-cell depletion and virus replication, we performed
concurrent kinetic measurements of these parameters in histocultures
infected by NL4-3 or 49-5. In a typical experiment, NL4-3 progressively depressed the overall CD4/CD8 ratio with early effects evident by day 3 and progressive effects on days 6 and 12 (Fig.
2A, left). In contrast, the effect of
49-5 on CD4/CD8 ratio was very modest at all time points (Fig. 2A,
right).
|
Stratification by CCR5 expression revealed a more complex pattern. In
NL4-3-infected cultures both CCR5
(Fig. 2B, left) and
CCR5+ (Fig. 2C, right) lymphocytes were lost markedly and
progressively over the 12-day period with kinetics that paralleled the
overall depletion of CD4+ T cells (Fig. 1A). In contrast,
49-5 had minimal effects on the CCR5
population (Fig. 2B,
right) but severely and progressively depleted CCR5+ cells
(Fig. 2C, right). In each of these cases, the kinetics of depletion of
CD4+ T cells overall corresponded to the kinetics of
depletion within the CCR5
population, which reflects the
small contribution of the minor CCR5+ pool. These kinetic
analyses provide further evidence that R5 viruses deplete T cells in a
coreceptor-dependent process leading to preferential loss of
CCR5+ cells. It should be noted that, in some experiments
with 49-5, partial loss of CCR5+ cells was detected by day
3 without further loss on subsequent days (data not shown). This
donor-specific effect suggests that under some conditions CCR5
expression is necessary but not sufficient for CD4+ T-cell
depletion by R5 viruses and that cellular properties other than
coreceptor expression may also influence susceptibility to depletion.
In view of the coreceptor-dependent depletion of major and minor T-cell
subsets by X4 and R5 strains, respectively, the relationship among
cellular coreceptor expression, productive viral infection, and cell
killing is not immediately evident. In particular, R5 and X4 viruses
differentially depleted CD4+ T cells yet exhibited similar
replication profiles. Also, we previously found that the frequencies of
productively infected lymphocytes were not consistently different in X4
and R5 virus-infected cultures as assessed at day 12 postinfection
(9). To clarify this apparent discrepancy, we concurrently
examined viral output and infected T-cell frequencies in infected
cultures. As described earlier, in a typical experiment NL4-3- and
49-5-infected tonsil histocultures produced nearly identical amounts of
virus with very similar kinetics as assessed by the p24 content of
culture supernatants (Fig. 3A). To
measure the frequency of infected cells in these cultures, cells were
harvested at various time points, coimmunostained with monoclonal
antibodies (MAbs) to CD3 and p24, and analyzed by flow cytometry. By
this measurement, at days 6 to 9 postinfection, NL4-3 productively
infected a relatively large proportion of the T cells, reaching
approximately 15% of total CD3+ lymphocytes and declining
by the end of the experiment (Fig. 3B). In contrast, 49-5 infected
fewer T cells, reaching approximately 5% of CD3+ cells
(Fig. 3B).
|
The difference in T-cell infection efficiency exhibited by these two
viruses corresponds to the more aggressive depletion effect of X4
viruses compared to that of R5 viruses, but it also represents a
paradox in the context of their very similar viral output profiles
(Fig. 3A). One hypothesis to account for this paradox is that
macrophages constitute an additional source of virus output that is not
reflected in the analysis of infected T cells. We therefore used
immunohistochemistry to visualize the full spectrum of infected cells
in these histocultures. Immunostaining of formalin-fixed tonsil
sections for the macrophage-specific antigen CD68 (6)
revealed large numbers of macrophages distributed throughout the tissue
(reference 4 and data not shown). Immunostaining for
p24 revealed striking differences between the X4 and R5 virus-infected cultures. NL4-3-infected tissue demonstrated a predominance of p24-positive cells that appeared to be lymphocytes based on their small
size and high nucleus/cytoplasm ratio (Fig.
4A, left, and 4B). In contrast, in
49-5-infected tissue many of the p24-positive cells appeared to be
macrophages, based on their large size and abundant cytoplasm (Fig. 4A,
right). Interestingly, some of these macrophage-like cells were also
p24-positive in the NL4-3-infected cultures, and these were
distinguishable as moderately and intensely stained cells. Likewise, a
small number of intensely staining p24-positive lymphocytes was
observed in the 49-5-infected samples. To compare target cell
frequencies quantitatively, p24-positive lymphocytes and
macrophage-like cells in the two cultures were counted by visual
inspection (Fig. 4B), which confirmed the strong but not absolute
preference of an X4 strain for lymphocytes and of an R5 strain for
macrophage-like cells. Thus, as analyzed by immunohistochemistry,
productive infection of both lymphocytes and macrophage-like cells
appears to contribute to the total output of virus in HIV-1-infected
histocultures.
|
We also developed a flow cytometric approach to identify and quantify macrophage-like cell types in HIV-infected lymphoid tissues. Macrophages were identified by immunostaining cells dispersed from histocultures for markers that distinguish T cells (CD3) from macrophages (CD14 and CD68). Cytospin and transmission electron microscopic analysis of cells sorted by positive staining for these markers validated this separation technique (data not shown). To analyze infection in this population, cells from infected tonsil histocultures were also immunostained for viral p24. These experiments demonstrated that the R5 virus infected a significantly higher proportion of macrophages in these tissues than did the matched X4 virus (Fig. 4C); similar results were obtained using two other distinct pairs of isogenic X4 and R5 viruses (data not shown). These results confirm that macrophages serve as significant cellular hosts for productive infection by R5 viruses, presumably contributing to the total viral output. The relative contribution macrophages make to replication of X4 viruses in these lymphoid tissues appears to be smaller (Fig. 4). Additionally, other cells not identified in this analysis (e.g., dendritic cells) may also contribute to total viral output in tonsil histocultures.
In the present studies of matched recombinant viruses, we confirmed that X4 HIV-1 strains are more pathogenic toward the overall CD4+ T-cell population than are isogenic R5 strains. We also verified that CXCR4 is expressed very widely among CD4+ T cells in these lymphoid cultures, while CCR5 is expressed on fewer cells. Correspondingly, all X4 strains depleted CD4+ T cells broadly in these experiments, while their matched R5 counterparts potently and preferentially depleted CD4+ T cells within the smaller CCR5+ pool. Additionally, the overall frequency of productively infected lymphocytes in X4 HIV-1-infected tissues is higher than in R5 HIV-1-infected tissues, suggesting that the measured frequencies of productively infected lymphocytes are proportional and related to the cumulative attrition of infected cells. These experiments strongly support the hypothesis that X4 viruses infect lymphocytes at high frequencies and exhibit high overall virulence because CXCR4-expressing targets are abundant, while R5 viruses are also pathogenic for cell targets but exhibit lower overall virulence because CCR5-expressing cells are much less abundant. Furthermore, they prove that sequences in gp120 controlling coreceptor specificity alone are sufficient to determine which subset of CD4+ T cells is depleted by each virus.
These principles should be relevant for other lymphoid organs as well (4, 9). Moreover, no consistent differences were observed between pathologic tonsil specimens and nonpathologic spleen specimens in the expression of various common markers of activation (data not shown), suggesting that a particular inflammatory state is not required for these viral properties to be manifest. In addition, CXCR4 and CCR5 expression patterns were comparable in these tissues (data not shown). However, there may be differences in relative activation status and/or coreceptor expression in other lymphoid tissues not examined here, such as gut-associated lymphoid tissue or thymus tissue. It is reasonable to expect that in these tissue contexts as well, the level of pathogenicity demonstrated by X4 and R5 viruses would be governed by the relative expression levels of CXCR4 and CCR5. For example, the level of CCR5 is significantly higher in gut-associated lymphoid tissue than in peripheral blood (7), and this tissue in rhesus monkeys was found to be highly susceptible to the pathogenic effects of an R5 simian immunodeficiency virus strain (14). In contrast, CCR5 expression in the human thymus is very low, and R5 viruses replicate poorly in this tissue and cause minimal cytopathic effects (2).
Despite differences in the pattern of selective CD4 depletion, X4 and R5 strains produced comparable amounts of virus with similar kinetics, in contrast to other reports based on xenotransplant model systems (2, 8, 10). The presence of significant numbers of tissue macrophages and dendritic cells is one feature that distinguishes the histoculture model (4). Indeed, we detected large, p24-positive macrophage-like cells in both R5- and X4-infected tissues by immunohistochemistry and flow cytometry. It is possible that this p24 staining represented cells that had endocytosed infected lymphocytes rather than those directly infected by HIV-1. By this interpretation, one would expect a higher proportion of p24-positive macrophage-like cells in X4-infected cultures, given the higher level of infection of T cells by these strains. However, a larger proportion of macrophage-like cells were found to be p24-positive in R5-infected cultures than in X4-infected cultures, making it likely that the majority of large, p24-positive cells represent direct and productive infection. Thus, macrophages may contribute to viral output for both virus types but make a greater contribution for R5 strains. Therefore, the combined viral output from infected T cells, macrophages, and possibly other related cell types not identified in these analyses could account for the overall similarities in replication kinetics. Unfortunately, current technology has not yet permitted a robust and direct determination of the actual sources of virus production in these histocultures. Nonetheless, one interesting speculation is that the relative contribution of cell types other than CD4+ T cells (e.g., macrophages) to viral load may increase over time in conjunction with progressive loss of specific T cells that are susceptible to the cytopathic effects of HIV-1.
These data provide compelling reasons to continue anti-HIV-1 therapeutic efforts aimed at developing antagonists to both CCR5 and CXCR4. Because macrophages can be infected detectably by both X4 and R5 strains, such antagonists may be effective not only in preventing CD4 depletion but also in limiting viral replication in alternative non-T-cell reservoirs.
| |
ACKNOWLEDGMENTS |
|---|
J.-C.G. and M.L.P. contributed equally to this work.
We thank Bruce Chesebro and Malcolm Martin for kindly providing plasmids and Dee J. Holthe, Cecilia Stewart, Sharon Hall, Claudette Delphis, Ursula Perotti, Mark Weinstein, and the surgical staffs at Kaiser Hospitals (San Rafael and San Francisco) and San Francisco General Hospital for generous assistance in obtaining posttonsillectomy samples. We acknowledge the technical assistance of Eric Wieder and Lisa Gibson in these experiments and the assistance of Heather Gravois, John Carroll, and Neile Shea in the preparation of the manuscript.
M.L.P. was supported by the California Universitywide AIDS Research Program, the Biomedical Sciences Graduate Program, and the National Institutes of Health Medical Scientist Training Program at UCSF. D.A.E. was supported by the National Institutes of Health Medical Scientist Training Program at UCSF. B.S. was supported by the Boehringer Ingelheim Fund, and R.F.S. was supported in part by the UCSF-GIVI CFAR. This work was supported in part by NIH grant R01-AI43695 (M.A.G.), the J. David Gladstone Institutes (M.A.G.), and the NASA/NIH Center for Three-Dimensional Tissue Culture.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address for Mark A. Goldsmith: Gladstone Institute of Virology and Immunology, P.O. Box 419100, San Francisco, CA 94141-9100. Phone: (415) 695-3775. Fax: (415) 695-1364. E-mail: mgoldsmith{at}gladstone.ucsf.edu. Mailing address for Leonid Margolis: N.I.H., Bldg. 10, Rm. 10D14, Bethesda, MD 20892. Phone: (301) 594-2476. Fax: (301) 480-0857. E-mail: margolis{at}helix.nih.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700[CrossRef][Medline]. |
| 2. |
Berkowitz, R. D.,
S. Alexander,
C. Bare,
V. Linquist-Stepps,
M. Bogan,
M. E. Moreno,
L. Gibson,
E. D. Wieder,
J. Kosek,
C. A. Stoddart, and J. M. McCune.
1998.
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo.
J. Virol.
72:10108-10117 |
| 3. | Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1996. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70:9055-9059[Abstract]. |
| 4. | Glushakova, S., B. Baibakov, J. Zimmerberg, and L. B. Margolis. 1997. Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res. Hum. Retrovir. 13:461-471[Medline]. |
| 5. | Grivel, J.-C., and L. B. Margolis. 1999. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat. Med. 5:344-346[CrossRef][Medline]. |
| 6. | Herndier, B. G., A. Werner, P. Arnstein, N. W. Abbey, F. Demartis, R. L. Cohen, M. A. Shuman, and J. A. Levy. 1994. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 8:575-581[Medline]. |
| 7. | Lapenta, C., M. Boirivant, M. Marini, S. M. Santini, M. Logozzi, M. Viora, F. Belardelli, and S. Fais. 1999. Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur. J. Immunol. 29:1202-1208[CrossRef][Medline]. |
| 8. | Mosier, D. E. 1996. Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv. Immunol. 63:79-125[Medline]. |
| 9. |
Penn, M. L.,
J. C. Grivel,
B. Schramm,
M. A. Goldsmith, and L. Margolis.
1999.
CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.
Proc. Natl. Acad. Sci. USA
96:663-668 |
| 10. |
Picchio, G. R.,
R. J. Gulizia,
K. Wehrly,
B. Chesebro, and D. E. Mosier.
1998.
The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.
J. Virol.
72:2002-2009 |
| 11. |
Riley, J. L.,
B. L. Levine,
N. Craighead,
T. Francomano,
D. Kim,
R. G. Carroll, and C. H. June.
1998.
Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis.
J. Virol.
72:8273-8280 |
| 12. | Speck, R. F., K. Wehrly, E. J. Platt, R. E. Atchison, I. F. Charo, D. Kabat, B. Chesebro, and M. A. Goldsmith. 1997. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:7136-7139[Abstract]. |
| 13. | Toohey, K., K. Wehrly, J. Nishio, S. Perryman, and B. Chesebro. 1995. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213:70-79[CrossRef][Medline]. |
| 14. |
Veazey, R. S.,
M. DeMaria,
L. V. Chalifoux,
D. E. Shvetz,
D. R. Pauley,
H. L. Knight,
M. Rosenzweig,
R. P. Johnson,
R. C. Desrosiers, and A. A. Lackner.
1998.
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.
Science
280:427-431 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»